Multi-target drug discovery (MTDD) is an emerging area of increasing interest to the drug discovery community. Drugs that modulate several targets have the potential for an improved balance of efficacy and safety compared to single targets agents. Although there are a number of marketed drugs that are thought to derive their therapeutic benefit by virtue of interacting with multiple targets, the majority of these were discovered accidentally. Written by world renowned experts, this is the first book to gather together knowledge and experiences of the rational discovery of multi-target drugs. It describes the current state of the art, the achievements and the challenges of the field and importantly the lessons learned by researchers to date and their application to future MTDD.

Bolognesi, M.L., Melchiorre, C., Van der Schyf, C.J., et al. (2012). Discovery of Multi-Target Agents for Neurological Diseases via Ligand Design. CAMBRIDGE : Royal Society of Chemistry [10.1039/9781849734912-00290].

Discovery of Multi-Target Agents for Neurological Diseases via Ligand Design

BOLOGNESI, MARIA LAURA;MELCHIORRE, CARLO;
2012

Abstract

Multi-target drug discovery (MTDD) is an emerging area of increasing interest to the drug discovery community. Drugs that modulate several targets have the potential for an improved balance of efficacy and safety compared to single targets agents. Although there are a number of marketed drugs that are thought to derive their therapeutic benefit by virtue of interacting with multiple targets, the majority of these were discovered accidentally. Written by world renowned experts, this is the first book to gather together knowledge and experiences of the rational discovery of multi-target drugs. It describes the current state of the art, the achievements and the challenges of the field and importantly the lessons learned by researchers to date and their application to future MTDD.
2012
Designing Multi-Target Drugs
290
315
Bolognesi, M.L., Melchiorre, C., Van der Schyf, C.J., et al. (2012). Discovery of Multi-Target Agents for Neurological Diseases via Ligand Design. CAMBRIDGE : Royal Society of Chemistry [10.1039/9781849734912-00290].
Bolognesi; M.L.; Melchiorre; C.; Van der Schyf; C.J.; and Youdim; M.B.H
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/119090
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 5
social impact